Transgene Sa Stock Probability of Future Pink Sheet Price Finishing Over 1.59

TRGNF Stock  USD 1.59  0.00  0.00%   
Transgene's future price is the expected price of Transgene instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Transgene SA performance during a given time horizon utilizing its historical volatility. Check out Transgene Backtesting, Transgene Valuation, Transgene Correlation, Transgene Hype Analysis, Transgene Volatility, Transgene History as well as Transgene Performance.
  
Please specify Transgene's target price for which you would like Transgene odds to be computed.

Transgene Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Transgene for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Transgene SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Transgene SA generated a negative expected return over the last 90 days
Transgene SA may become a speculative penny stock
Transgene SA has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 9.99 M. Net Loss for the year was (19.54 M) with loss before overhead, payroll, taxes, and interest of (15.87 M).
Transgene SA has accumulated about 49.57 M in cash with (31.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5.

Transgene Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Transgene Pink Sheet often depends not only on the future outlook of the current and potential Transgene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Transgene's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding83.8 M

Transgene Technical Analysis

Transgene's future price can be derived by breaking down and analyzing its technical indicators over time. Transgene Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Transgene SA. In general, you should focus on analyzing Transgene Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Transgene Predictive Forecast Models

Transgene's time-series forecasting models is one of many Transgene's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Transgene's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Transgene SA

Checking the ongoing alerts about Transgene for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Transgene SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Transgene SA generated a negative expected return over the last 90 days
Transgene SA may become a speculative penny stock
Transgene SA has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 9.99 M. Net Loss for the year was (19.54 M) with loss before overhead, payroll, taxes, and interest of (15.87 M).
Transgene SA has accumulated about 49.57 M in cash with (31.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5.

Other Information on Investing in Transgene Pink Sheet

Transgene financial ratios help investors to determine whether Transgene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transgene with respect to the benefits of owning Transgene security.